Literature DB >> 28511240

[Treatment Outcome in Female In-Patients with Anorexia nervosa and Comorbid Personality Disorders Prevalence - Therapy Drop out and Weight Gain].

Timo Maximilian Link1, Ursula Beermann1, Robert Mestel2, Manuela Gander3,1.   

Abstract

Introduction Personality disorders (PD) are among the most common comorbid disorders in female patients with Anorexia Nervosa (AN). Recent research findings suggest that comorbid PD are associated with a higher treatment drop-out rate and a worse therapeutic outcome. However, no study to date has distinguished between certain age groups concerning these issues. Research questions Therefore, the present study focuses on the prevalence of PD (1), treatment drop-out rates (2) and weight gain (3) in female in-patients with AN. Thereby, we differentiate among three age groups (17-24 years; 25-34 years; 35-65 years). Material & Methods We assessed female in-patients (N=331) with AN at the Helios Clinic in Bad Grönenbach in Germany using the Eating Disorders Inventory-2 and the psychotherapeutic-medical basic documentation at the beginning and at the end of their treatment. Furthermore, we investigated the drop-out rate and weight gain by comparing anorexic patients with and without comorbid PD that were diagnosed by clinicians using ICD-10 criteria. Results In sum, our patients with AN demonstrated a prevalence rate of 34% for one or more comorbid PD. Interestingly, patients between 17-24 years showed a lower prevalence rate of 22% compared to those between 25-34 years (42%) and 35-65 years (41%). Furthermore, younger age and comorbid PD seemed to be significant predictors for treatment dropout. One of the most striking results was that younger patients (17-24) without a comorbid PD had the highest weight gain during treatment. This could not be observed in patients with a comorbid PD, who demonstrated the highest weight gain between 25 and 34 years of age. Conclusion Our findings support the hypothesis that comorbid PD are related to a worse outcome in patients with eating disorders. Future studies might do well in assessing dimensional scores of personality disorders and other relevant aspects like for example the amount of social support to draw further conclusions on these associations. Our results emphasize the need for more disorder-specific interventions tailoring at patients with AN and comorbid PD to improve treatment outcome. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28511240     DOI: 10.1055/s-0043-103271

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  5 in total

1.  Psychiatric comorbidity as a risk factor for mortality in people with anorexia nervosa.

Authors:  Hubertus Himmerich; Matthew Hotopf; Hitesh Shetty; Ulrike Schmidt; Janet Treasure; Richard D Hayes; Robert Stewart; Chin-Kuo Chang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-08-17       Impact factor: 5.270

2.  Influence of Identity Development on Weight Gain in Adolescent Anorexia Nervosa.

Authors:  Lynn I Budde; Simon Wilms; Manuel Föcker; Anke Dalhoff; Joerg M Müller; Ida Wessing
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

3.  [3-year course after successful therapy of extreme anorexia nervosa].

Authors:  U Voderholzer; M Fumi; J Werz; T Körner; U Cuntz
Journal:  Nervenarzt       Date:  2018-09       Impact factor: 1.214

4.  Transitions from intensive eating disorder treatment settings: qualitative investigation of the experiences and needs of adults with anorexia nervosa and their carers.

Authors:  Danielle Clark Bryan; Pamela Macdonald; Valentina Cardi; Katie Rowlands; Suman Ambwani; Jon Arcelus; Eva-Maria Bonin; Sabine Landau; Ulrike Schmidt; Janet Treasure
Journal:  BJPsych Open       Date:  2022-07-20

5.  The Maudsley Anorexia Nervosa Treatment for Adults (MANTRA): a feasibility case series of an integrated group based approach.

Authors:  Helen Startup; Mary Franklin-Smith; William Barber; Nicola Gilbert; Yael Brown; Danielle Glennon; Akira Fukutomi; Ulrike Schmidt
Journal:  J Eat Disord       Date:  2021-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.